Geovax next-generation covid-19 vaccine data to be presented at two upcoming scientific meetings

Presentations to include new and unpublished data from phase 2 open-label safety study of geo-cm04s1 atlanta, ga, may 15, 2023 (globe newswire) -- via newmediawire –  geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that it will be represented during two upcoming scientific meetings, including vaccines summit boston 2023 in boston, ma, may 22-24, 2023 and cyto 2023 in montrÉal, quÉbec, canada, may 20-24, 2023. vaccines summit presentation: monday, may 22, 2023, 3:00 pm -3:30 pm et, session talks – ii on monday, may 22, don diamond, ph.d.
GOVX Ratings Summary
GOVX Quant Ranking